Pharma consultant Michele Bruschi breaks down why 80% of CDMOs and biotechs are still managing critical operations with spreadsheets and PDFs - and how this data crisis is creating massive competitive advantages for the companies that solve it.

In this episode, we explore:

• Why "endless searching" for SOPs is costing weeks on every project
• How disconnected systems create operational chaos across the industry
• Why efficiency and speed have replaced capacity as key differentiators
• The hidden costs of fragmented data management (13:49)
• What operational differentiation actually looks like in practice (20:08)
• Michele's prediction on which companies will survive the current market consolidation

Michele brings insider perspective on the pharmaceutical industry's data management challenges and reveals why now is the critical moment for digital transformation in bioprocessing.

Whether you're a biotech approaching tech transfer or a CDMO looking to differentiate, this conversation explains the operational realities shaping partnership decisions today.

Guest: Michele Bruschi, Pharmaceutical Industry ConsultantHost: Nicholas Crudele, Method Made